CD33 (Myeloid Cell Marker)

The CD15 (Myeloid Cell Marker) test is a flow cytometry test that identifies and quantifies the number of myeloid cells present in a blood or bone marrow sample. Myeloid cells play a crucial role in the functioning of the immune system. These cells facilitate the production of different types of cells such as granulocytes, monocytes, and dendritic cells. Myeloid cells are also responsible for fighting against bacterial and fungal infections.

In some instances, abnormal production of myeloid cells can occur, leading to serious health conditions such as acute myeloid leukaemia (AML), myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN). The CD15 (Myeloid Cell Marker) test is a reliable and accurate method for detecting abnormalities in myeloid cells. It is also used to monitor the effectiveness of treatment being provided to patients with myeloid disorders.

Symptoms

Fatigue and weakness are common symptoms associated with many illnesses, including those that can be detected through the CD15 (Myeloid Cell Marker) test. Loss of appetite, unexplained weight loss, night sweats, shortness of breath, fever and chills, bone or joint pain, and swollen lymph nodes are also signs that may indicate the presence of a serious condition. If any of these symptoms persist, it is important to consult a doctor immediately for proper diagnosis and treatment.

Test Procedure:

The sample for the CD15 (Myeloid Cell Marker) test is obtained through a bone marrow aspiration procedure. A small needle is inserted into the bone marrow cavity to extract a sample of the bone marrow. This procedure may be performed by a haematologist or an oncologist.

After the bone marrow aspirate is obtained, it is sent to a laboratory for testing. The test involves using antibodies that specifically target the CD15 antigen on the surface of myeloid cells. The bone marrow sample is then analysed using flow cytometry to determine if there is an abnormal number of myeloid cells present.

Treatment:

A positive CD15 (Myeloid Cell Marker) test result indicates the presence of abnormal myeloid cells in the blood, which can be an indication of several conditions. Therefore, additional tests may be needed to confirm the diagnosis and determine the severity of the condition. For example, a bone marrow biopsy may be required to examine the myeloid cells more closely and identify the type of myeloid disorder.

The treatment options for myeloid disorders vary depending on the type of condition and the severity of the disease. In some cases, no treatment may be required, and the patient may be monitored regularly to track the progress of the condition. However, if treatment is necessary, it may involve chemotherapy, radiation therapy, or bone marrow transplant, among other targeted therapies.

Benefits of an Early Diagnosis:

Early diagnosis can make a significant difference in the outcome of a serious condition. Detecting a disease in its early stages can prevent the condition from progressing to a severe stage. This is particularly true for conditions that can be detected through the CD15 (Myeloid Cell Marker) test, as they can be life-threatening if not detected and treated on time.

In addition to facilitating early intervention, the test also helps individuals to take charge of their health and make lifestyle changes that can promote better health outcomes. For instance, if a CD15 (Myeloid Cell Marker) test comes back positive, a patient can take steps to adopt a healthy diet and exercise routine, reduce stress levels, and quit smoking. These lifestyle changes can help reduce the risk of complications and promote better overall health.

Booking a CD15 (Myeloid Cell Marker) test on Apollo 24|7 is a simple process. Patients can visit the website or open the app and select CD15 (Myeloid Cell Marker) from the list of available tests. They can then select a time slot that is convenient for them and complete the booking process. Once patients book the test online, they will receive a confirmation message containing all the necessary information regarding the test, such as the date, time, and location. Results for this test are typically available within 72 hours.